Our website is currently being updated and you may experience some limited functionality at this time.

LED BY SCIENTIFIC EXPERTISE

IVD: Intervene Vs. Damage

In Vitro Diagnostics

In-Vitro Diagnostics Company

ProAxsis, based in Northern Ireland develops and supplies diagnostic assays to improve patients’ outcomes by identifying biomarkers for clinical intervention.

ProAxsis develops and supplies diagnostic assays focusing on biomarkers that aid clinical intervention which ultimately leads to improve patients’ outcomes.

ProAxsis develops and supplies diagnostic assays focusing on biomarkers that aid clinical intervention which leads to improved patient outcomes.

ProAxsis Limited is a commercial-stage diagnostics company, based in Northern Ireland, and with a rapidly growing client list of pharmaceutical companies and academic laboratories.

Get Started

How We Work

Academic and pharmaceutical Research

Range of assay kits, analytical services and R&D services designed for specific measurement of proteases and other inflammatory biomarkers of disease

Health Care Professionals

Enhancing clinical picture and providing point of care tests for respiratory disease patient

0 +

Over 10 years of expert led research and development

Precision technology scientifically led

Market and clinically inspired portfolio developed through scientific expertise and our valued partners

Products:

ProAxsis has developed a range of products incorporating their patented technology aiding the identification of Active proteases – validated biomarkers of disease activity.

Clinical Services and R&D Projects:

ProAxsis offer a range of contract services from protease biomarker investigation, clinical trial and pharma services to academic support services

ABOUT PROAXSIS .

We specialise in a number of key areas

Proaxsis specializes in key areas

Assay Kits

Products:

Laboratory Analysis

Contract Services:

Mission

At ProAxsis, we design, manufacture and supply industry leading products and services including our Innovative Patented Technology, ProteaseTag®, to tertiary centres, research sites and pharmaceutical companies across the globe. Equally, our inhouse expertise offers clinical services that supports the identification of active biomarkers, accelerating clinical decision making and better patient outcomes.

Vision

At the heart of ProAxsis is the relentless pursuit in identifying key biomarkers and developing products and technologies satisfying the unmet needs of healthcare professionals across the globe. Key chronic diseases including, but not limited to, COPD, Bronchiectasis and Cystic Fibrosis, benefit from the specificity and sensitivity of ProAxsis kits whilst the services available are provided with precision and accuracy.

Learn More

ABOUT PROAXSIS

We specialise in a number of key areas

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat Duis aute irure dolor in reprehenderit.

Assay Kits

Sample analysis for proteases and inflammatory biomarkers, assay development, Neutrophil elastase assay, NEATstik point of care test and In-Vitro Diagnostics

Laboratory Analysis

Laboratory services, clinical research and bespoke R&D projects

0 ⁺

Awards Winning

0 ⁺

Our Equipments

0 ⁺

Field Expertise

0 ⁺

Industry Expertise

OUR SPECIALITIES Explore Our Main Services

Learn more

The company designs a range of assay kits for the measurement of active protease markers of disease

Clinical Trial Support Services

Biomarkers

R&D Projects

Clinical Research Services

Clinical Trial Support Services

R&D Projects

OUR SPECIALITIES

Explore Our Main Services

The company designs a range of assay kits for the measurement of active protease markers of disease

Clinical Research Services

Sample analysis for proteases ad inflammatory biomarkers

R&D projects

Bespoke Assay Development, Peptide-based inhibitor design and synthesis, Enzyme kinetics and compound characterisation, Activity-based steady state assays, SDS-PAGE and western blotting, ELISAs, Activity-based Immunoassays